Moderna stock surges on promising mRNA cancer treatment

By The BriefBrief

Moderna’s biotech value nearly triples after its mRNA cancer treatment showed promise, reviving investor interest in the company after years of struggle.

WHO: Moderna

WHAT: Moderna’s mRNA cancer treatment shows promise, driving the company’s biotech value to nearly triple.

WHEN: Reported Aug 19, 2026 at 8:00 PM ET

WHERE: Location not specified

WHY: Cause not yet established.

How this story developed (showing 2 of 2 earlier reports)

Moderna cancer-vaccine breakthrough lifts biopharma stocks · Aug 19, 2026 at 4:06 PM ET
Moderna stock doubles on promising cancer-vaccine results · Aug 19, 2026 at 9:06 AM ET

Reporting from 4 identified publishers across this event arc.

View all 4 publishers

Publishers represented across this event arc

CNBC Top News — View reporting
Financial Times —
2 articles
- View article 1
- View article 2
MarketWatch —
2 articles
- View article 1
- View article 2
PBS NewsHour — View reporting

These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.

How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.

Know more. Read less.

The BriefBrief — updated continuously, every category, every day.

Emails show ICE and Iran coordinated deportations

Immigration Aug 20, 2026 at 12:07 PM ET

Bitcoin and ethereum rise as investors return to crypto

Bitcoin Aug 20, 2026 at 12:06 PM ET

FBI seizes Swalwell’s devices at SFO amid misconduct probe

Fbi Aug 20, 2026 at 12:06 PM ET

Manuel Hernandez arrested by ICE after Liberty Island boat

Ice Aug 20, 2026 at 12:06 PM ET

First Previous 9021 9022 9023 9024 9025 Next Last

Page 9023 of 21463